Anshuman Verma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anshuman Verma has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Muralidhar Ramappa
L V Prasad Eye Institute
2 shared publications - Anthony J. Aldave
Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA
1 shared publication Chitra Kannabiran
LV Prasad Eye Institute
1 shared publicationDeeksha Prasad
LV Prasad Eye Institute
1 shared publication- Deepak P. Edward
King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
1 shared publication - Dilip Kumar Mishra
Ophthalmic Pathology Laboratory, L V Prasad Eye Institute, Hyderabad, India
1 shared publication
Latest Publications
- 31 August 2026
- Published by Wolters Kluwer Health in Cornea
A Novel GRHL2 Intronic Variant in Familial Posterior Polymorphous Corneal Dystrophy: Clinical, Histopathological, and Genetic Insights Across Generations
Purpose: To describe the clinical, histopathological, and genetic characteristics of a posterior polymorphous corneal dystrophy-4 pedigree spanning 3 generations with a novel GRHL2 variant and to highlight intrafamilial clinical variability. Methods: Comprehensive ophthalmic examinations were performed on affected family members. Histopathological evaluation of proband's corneal tissue excised during penetrating keratoplasty was conducted using hematoxylin & eosin, periodic acid–Schiff, and cytokeratin stains. Genomic DNA was analyzed using Sanger sequencing of the promoter and coding regions of ZEB1, GRHL2 , and OVOL2 . Results: The proband and her sibling exhibited steep corneas with variable ground-glass haze, vesicular, and band-like endothelial changes. The mother and maternal grandfather showed milder endothelial vesicles and subtle posterior stromal haze, with the grandfather least affected. Histopathology showed posterior stromal thickening with edema, Descemet membrane reduplication, and thinning along with endothelial loss. Genetic analysis identified a novel heterozygous intronic GRHL2 variant (c.20 + 544G > C) segregating in all affected members, absent in 80 controls, and located in a known regulatory hotspot associated with ectopic GRHL2 expression. Conclusions: Intronic regulatory variants of GRHL2 can cause familial posterior polymorphous corneal dystrophy (PPCD) with marked phenotypic variability. This is the first report of the c.20 + 544G > C variant and the second implicating the same intronic position in PPCD, underscoring the diagnostic importance of this hotspot and the need to include regulatory regions in targeted genetic testing for PPCD.
- 31 August 2026
- Published by Wolters Kluwer Health in Cornea
A Novel GRHL2 Intronic Variant in Familial Posterior Polymorphous Corneal Dystrophy: Clinical, Histopathological, and Genetic Insights Across Generations
Purpose: To describe the clinical, histopathological, and genetic characteristics of a posterior polymorphous corneal dystrophy-4 pedigree spanning 3 generations with a novel GRHL2 variant and to highlight intrafamilial clinical variability. Methods: Comprehensive ophthalmic examinations were performed on affected family members. Histopathological evaluation of proband's corneal tissue excised during penetrating keratoplasty was conducted using hematoxylin & eosin, periodic acid–Schiff, and cytokeratin stains. Genomic DNA was analyzed using Sanger sequencing of the promoter and coding regions of ZEB1, GRHL2 , and OVOL2 . Results: The proband and her sibling exhibited steep corneas with variable ground-glass haze, vesicular, and band-like endothelial changes. The mother and maternal grandfather showed milder endothelial vesicles and subtle posterior stromal haze, with the grandfather least affected. Histopathology showed posterior stromal thickening with edema, Descemet membrane reduplication, and thinning along with endothelial loss. Genetic analysis identified a novel heterozygous intronic GRHL2 variant (c.20 + 544G > C) segregating in all affected members, absent in 80 controls, and located in a known regulatory hotspot associated with ectopic GRHL2 expression. Conclusions: Intronic regulatory variants of GRHL2 can cause familial posterior polymorphous corneal dystrophy (PPCD) with marked phenotypic variability. This is the first report of the c.20 + 544G > C variant and the second implicating the same intronic position in PPCD, underscoring the diagnostic importance of this hotspot and the need to include regulatory regions in targeted genetic testing for PPCD.
- 1 May 2024
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 45 (4) , 395-400
GAPO syndrome: a novel variant in ANTXR1 gene
Background: GAPO syndrome is a rare autosomal recessive disorder characterized by the acronym of growth retardation, alopecia, pseudo-anodontia and progressive optic atrophy. While the genetic alteration of the ANTXR1 gene has been known for its cause, the full range of its clinical and genetic manifestations is not well explored due to the syndrome's extreme rarity. Materials/Methods: We report two children born to a non-consanguineous parent in India with classical features of GAPO syndrome. The whole exome sequencing analysis (WES) was performed in both siblings, and the parent's genetic and clinical status was determined. The identified variation was characterized in silico using homology-based protein modelling. Results: In WES analysis, a homozygous ANTXR1 gene indel variant c. 151_152 + 2delAAGT (p.Lys51fs) was identified in both siblings. The parents were identified as the carriers of the ANTXR1 variant. Additionally, they also displayed mild GAPO-related facial and glaucomatous features. In silico analysis and homology-based ANTXR1 protein structure illustrate a frameshift and the subsequent premature truncation of the protein. Conclusions: Our reports contribute to the comprehension of GAPO syndrome within the Indian context describing an ANTXR1 novel variant causing premature protein truncation. WES-based genetic testing can significantly aid in expertly diagnosing GAPO syndrome. In the present case scenario, a variable penetrance of ANTXR1 variation was acknowledged as the carrier parents also had a mild degree of GAPO-related features. Future reports that include parental clinical diagnosis can offer further insights in this context.
- 1 May 2024
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 45 (4) , 395-400
GAPO syndrome: a novel variant in ANTXR1 gene
Background: GAPO syndrome is a rare autosomal recessive disorder characterized by the acronym of growth retardation, alopecia, pseudo-anodontia and progressive optic atrophy. While the genetic alteration of the ANTXR1 gene has been known for its cause, the full range of its clinical and genetic manifestations is not well explored due to the syndrome's extreme rarity. Materials/Methods: We report two children born to a non-consanguineous parent in India with classical features of GAPO syndrome. The whole exome sequencing analysis (WES) was performed in both siblings, and the parent's genetic and clinical status was determined. The identified variation was characterized in silico using homology-based protein modelling. Results: In WES analysis, a homozygous ANTXR1 gene indel variant c. 151_152 + 2delAAGT (p.Lys51fs) was identified in both siblings. The parents were identified as the carriers of the ANTXR1 variant. Additionally, they also displayed mild GAPO-related facial and glaucomatous features. In silico analysis and homology-based ANTXR1 protein structure illustrate a frameshift and the subsequent premature truncation of the protein. Conclusions: Our reports contribute to the comprehension of GAPO syndrome within the Indian context describing an ANTXR1 novel variant causing premature protein truncation. WES-based genetic testing can significantly aid in expertly diagnosing GAPO syndrome. In the present case scenario, a variable penetrance of ANTXR1 variation was acknowledged as the carrier parents also had a mild degree of GAPO-related features. Future reports that include parental clinical diagnosis can offer further insights in this context.
- Open Access
- 13 May 2022
- Published by Springer Nature in Research Square
Identifications and in silico analysis of a spectrum of SLC4A11 mutations in Indian familial and non-familial cases of congenital hereditary endothelial dystrophy
Background: Congenital hereditary endothelial dystrophy (CHED) is a rare form of corneal dystrophy and is known to be caused by SLC4A11 gene mutation. The purpose of this study is to find genetic alterations in SLC4A11 using direct sequencing in two Indian familial CHED cases with affected members n=3 and n=2 respectively and five non-familial cases with a single affected member, followed by in silico characterization of identified mutations. Results: All three affected members of the first CHED family were identified with novel hom. c.1514C>G (p.Ser489Trp) mutation while second family showed presence of novel compound heterozygous mutation- het c.529A>C (p.Arg161Arg) + het c.2461insT (p.Val805fs). Among five non-familial cases, two showed novel changes hom. c.1487G>T (p.Ser480Ile) and hom. c.620-2A>G respectively, while the other one had previously reported hom. c.2653C>T (p.Arg869Cys) mutation. The remaining two cases did not reveal the presence of SLC4A11 related pathogenic mutations. Identified mutations were excluded from a large number of controls (n=80) and analyzed in silico using homology-based protein modeling and pathogenicity prediction tools, which predicted these alterations to be pathogenic causing change in protein stability, protein local flexibility and decrease in hydrogen bond interactions. Conclusions: Our study contributed to CHED mutational spectrum adding four novel mutations and confirming a previously reported mutation. Our study demonstrated a spectrum of mutations ranging from coding, non-coding, homozygous, and synonymous compound heterozygous in CHED cases. The identified mutations demonstrated different degrees of pathogenic effects based on in silico analysis. In addition, two non-familial cases could not be identified with pathogenic mutation emphasizing the involvement of other genes or genetic mechanisms for such cases.
- 13 May 2022
- Published by Springer Nature in Research Square
Open AccessIdentifications and in silico analysis of a spectrum of SLC4A11 mutations in Indian familial and non-familial cases of congenital hereditary endothelial dystrophy
Background: Congenital hereditary endothelial dystrophy (CHED) is a rare form of corneal dystrophy and is known to be caused by SLC4A11 gene mutation. The purpose of this study is to find genetic alterations in SLC4A11 using direct sequencing in two Indian familial CHED cases with affected members n=3 and n=2 respectively and five non-familial cases with a single affected member, followed by in silico characterization of identified mutations. Results: All three affected members of the first CHED family were identified with novel hom. c.1514C>G (p.Ser489Trp) mutation while second family showed presence of novel compound heterozygous mutation- het c.529A>C (p.Arg161Arg) + het c.2461insT (p.Val805fs). Among five non-familial cases, two showed novel changes hom. c.1487G>T (p.Ser480Ile) and hom. c.620-2A>G respectively, while the other one had previously reported hom. c.2653C>T (p.Arg869Cys) mutation. The remaining two cases did not reveal the presence of SLC4A11 related pathogenic mutations. Identified mutations were excluded from a large number of controls (n=80) and analyzed in silico using homology-based protein modeling and pathogenicity prediction tools, which predicted these alterations to be pathogenic causing change in protein stability, protein local flexibility and decrease in hydrogen bond interactions. Conclusions: Our study contributed to CHED mutational spectrum adding four novel mutations and confirming a previously reported mutation. Our study demonstrated a spectrum of mutations ranging from coding, non-coding, homozygous, and synonymous compound heterozygous in CHED cases. The identified mutations demonstrated different degrees of pathogenic effects based on in silico analysis. In addition, two non-familial cases could not be identified with pathogenic mutation emphasizing the involvement of other genes or genetic mechanisms for such cases.
- Open Access
- 18 March 2013
- Published by Springer Nature in BMC Research Notes
- Vol. 6 (1) , 103
Investigation of VSX1 sequence variants in South Indian patients with sporadic cases of keratoconus
Background: The involvement of VSX1 gene for the genetic basis of keratoconus is unclear and controversial. The genetic screening of VSX1 from different ethnic populations can enlighten this subject. The aim of the present study is to investigate the role of VSX1 gene in patients with sporadic cases of keratoconus from South India. Methods: The VSX1 gene coding regions, including exon-intron boundaries were screened by direct sequencing analysis in 117 sporadic cases of keratoconus. The identified variations were also analyzed in 108 ethnic matched healthy blood donors. Results: In the VSX 1 gene screening, no pathogenic mutation was identified, whereas we could find the presence of four reported single nucleotide polymorphisms; c.546A>G (rs12480307), c.627+23G>A (rs6138482), c.627+84T>A (rs56157240) and c.504-24C>T (IVS3-24C). These variations were observed in similar frequency between cases and controls. Conclusions: The lack of VSX1 pathogenic variations in a large number of unrelated sporadic keratoconus patients tend to omit its role, and corroborate the involvement of other genetic, environmental or behavioural factors in the development of this complex disorder.
- 18 March 2013
- Published by Springer Nature in BMC Research Notes
- Vol. 6 (1) , 103
Open AccessInvestigation of VSX1 sequence variants in South Indian patients with sporadic cases of keratoconus
Background: The involvement of VSX1 gene for the genetic basis of keratoconus is unclear and controversial. The genetic screening of VSX1 from different ethnic populations can enlighten this subject. The aim of the present study is to investigate the role of VSX1 gene in patients with sporadic cases of keratoconus from South India. Methods: The VSX1 gene coding regions, including exon-intron boundaries were screened by direct sequencing analysis in 117 sporadic cases of keratoconus. The identified variations were also analyzed in 108 ethnic matched healthy blood donors. Results: In the VSX 1 gene screening, no pathogenic mutation was identified, whereas we could find the presence of four reported single nucleotide polymorphisms; c.546A>G (rs12480307), c.627+23G>A (rs6138482), c.627+84T>A (rs56157240) and c.504-24C>T (IVS3-24C). These variations were observed in similar frequency between cases and controls. Conclusions: The lack of VSX1 pathogenic variations in a large number of unrelated sporadic keratoconus patients tend to omit its role, and corroborate the involvement of other genetic, environmental or behavioural factors in the development of this complex disorder.